8-Benzyloxy-3’-deoxyguanosine
8-Benzyloxy-3’-deoxyguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[2389988-57-0]
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/8-benzyloxy-3-deoxyguanosine.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1C[C@@H](O)[C@H](N2C(OCC3=CC=CC=C3)=NC4=C2NC(N)=NC4=O)O1
Molecular Formula
C17H19N5O5
Molecular Weight
373.36
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Pbx1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Rabbit Polyclonal BTF3L4 Antibody - Azide and BSA Free
Recombinant Bordetella Avium ruvA Protein (aa 1-190)
Recombinant Bacillus subtilis UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 (murAA)
Recombinant Bacillus subtilis UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 (murAA)